Source link : https://newshealth.biz/health-news/fda-widens-indication-of-finerenone-for-heart-failure-pts/
The FDA has expanded the indications of finerenone to include patients with heart failure with a left ventricular ejection fraction (LVEF) of at least 40%. The expanded approval for finerenone, a nonsteroidal mineralocorticoid receptor antagonist developed by Bayer, comes on the strength of the phase 3 FINEARTS-HF trial, published last year in the New England […]
The post FDA Widens Indication of Finerenone for Heart Failure Pts first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-16 18:43:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8